Page last updated: 2024-08-23

etoposide and Convalescence

etoposide has been researched along with Convalescence in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Brustugun, OT; Engleson, J; Fløtten, Ø; Grønberg, BH; Halvorsen, TO; Hornslien, K; Killingberg, KT; Langer, SW; Madebo, T; Nyman, J; Risum, S; Schytte, T; Tsakonas, G1

Trials

1 trial(s) available for etoposide and Convalescence

ArticleYear
Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 2022, Volume: 166

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Convalescence; Deglutition Disorders; Dose Fractionation, Radiation; Dyspnea; Etoposide; Humans; Lung Neoplasms; Neoplasm Staging; Patient Reported Outcome Measures; Quality of Life; Radiotherapy; Small Cell Lung Carcinoma

2022